Faculty profile

Shahid Ahmed

ResearcherMedicine/OncologyUniversity of Saskatchewan

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses and email address may be missing. Find their university profile.

Shahid Ahmed

Researcher

Medicine/Oncology

Health Sciences

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
41 publications in the last five years, latest in 2026.
Senior (last) author on 18 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biomarkers Chemotherapy Liver Metastases Metastasectomy Metastatic Colorectal Cancer Pet Scan Quality Of Life Survival

Latest papers

Diabetes Mellitus and Survival Outcomes in Women With Early-Stage Triple-Negative Breast Cancer: A Multicentre Population-Based Cohort Study From Saskatchewan.
Canadian journal of diabetes · 2026 · senior author
Signals of inequity in the care pathway: rural lab diagnosis, systemic therapy delays, and RAS mutation differences in metastatic colorectal cancer.
Frontiers in oncology · 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026

All 85 publications

Latest funding

Telomere-Directed Epigenetic Therapy: A Novel Approach for Treating Pancreatic Ductal Adenocarcinoma.
CIHR · 2025 · Co-investigator
$1,105,426
A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).
CIHR · 2025 · Co-investigator
$600,000
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)
CIHR · 2021 · Co-investigator
$1,426,724

All 5 grants and awards

85 publications.

Diabetes Mellitus and Survival Outcomes in Women With Early-Stage Triple-Negative Breast Cancer: A Multicentre Population-Based Cohort Study From Saskatchewan.

Shahid RK, Brabant M, Mondal P, Ahmed O, Manna M, Ahmed S

Canadian journal of diabetes2026Senior author

DOI: 10.1016/j.jcjd.2026.05.005 PMID: 42173241

Signals of inequity in the care pathway: rural lab diagnosis, systemic therapy delays, and RAS mutation differences in metastatic colorectal cancer.

Ismail A, Dahanayake A, Ahmed S, Pillay Y, Khatib A

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1826846 PMID: 42311259

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ

Signal transduction and targeted therapy2026

DOI: 10.1038/s41392-026-02750-0 PMID: 42236690

Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges.

Habib R, Arnold E, Obi T, Vizeacoumar FJ, Ahmed S

Current oncology (Toronto, Ont.)2026Senior author

DOI: 10.3390/curroncol33080452 PMID: 42645357

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.

Lee-Ying R, Gill S, Box A, Latour H, Strum S, Gordon V, Wong R, Grendarova P, Gimon T, Ahmed S, Geller G, Kim C, Le D, Mulder K, Paul J, Gowrishankar B

Current oncology (Toronto, Ont.)2026

DOI: 10.3390/curroncol33070437 PMID: 42505238

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Ahmed S, Mannala S, Mondal P, Mahmood W, Chalchal HI, Dwernychuk L, Iqbal N, Salim M, Khan MI, Ahmed O, Manna M, Leverick DG, Chandrasekhar A, Bashir A, Haider K, Leis A, Kontulainen S, Sami A

Breast cancer research and treatment2026First author

DOI: 10.1007/s10549-026-07999-1 PMID: 42360361

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Chan KKW, Chu RWK, Cheung MC, Courneya KS, O'Callaghan CJ, Vardy JL, Gill S, Friedenreich C, Wong RKS, Dhillon HM

Journal of Clinical Oncology20261 citations

DOI: 10.1200/jco-26-00765

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.

Gotfrit J, Marginean H, Ko YJ, Ghafoor A, Kavan P, Chalchal H, Ahmed S, Mulder K, Tang P, Goodwin R

Current oncology (Toronto, Ont.)2025

DOI: 10.3390/curroncol32030128 PMID: 40136332

Platelet proteomics: Clinical implications - Decoding the black box!

Goubran H, Ahmed S, Ragab G, Seghatchian J, Burnouf T

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2025

DOI: 10.1016/j.transci.2024.104060 PMID: 39719751

Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome in patients with cancer: A multicentre study.

Shahid RK, Haider Q, Yadav S, Le D, Ahmed S

Clinical medicine (London, England)2025Senior author

DOI: 10.1016/j.clinme.2024.100262 PMID: 39522614

Something wrong or missing on this profile? Suggest a correction

Shahid Ahmed

Research

Latest papers

Latest funding

Diabetes Mellitus and Survival Outcomes in Women With Early-Stage Triple-Negative Breast Cancer: A Multicentre Population-Based Cohort Study From Saskatchewan.

Signals of inequity in the care pathway: rural lab diagnosis, systemic therapy delays, and RAS mutation differences in metastatic colorectal cancer.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges.

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.

Platelet proteomics: Clinical implications - Decoding the black box!

Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome in patients with cancer: A multicentre study.

Telomere-Directed Epigenetic Therapy: A Novel Approach for Treating Pancreatic Ductal Adenocarcinoma.

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)

Conversion From Unresectable To Resectable Liver Metastases In Patients With Liver-Only Metastatic Colorectal Cancer Treated With FOLFOXIRI Plus Bevacizumab. The Conversion Trial.

Extending the Reach: Ethnodrama, Knowledge Translation, and Breast Cancer Survivorship.

Frequent collaborators

Punam Pahwa

Gary Groot

Anne Leis

Jim Xiang

Devin Schellenberg

Andrew Freywald

Martine Puts

Anand Krishnan

Jennifer Nuk

Kiat Tan

Linda Mcmullen

Sylvia Abonyi

Elizabeth Quinlan

Roanne Thomas

Michael Brundage

Aneesh Thakur

Deepesh Lad

Nick Baniak

Christopher Eskiw

Laura Dawson

Sukhbinder Dhesy-Thind

Graham Dellaire

James Dosman

Ralph Meyer

Sabine Mai

Hira Mian

Saija Kontulainen

Christine Friedenreich